Fundraising Fox
/Companies
Sign in

Genespire

4 known investors

Find your way into Genespire

Sign up to see every warm intro you have to Genespire

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Genespire team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Genespire is a life sciences company backed by multiple venture capital investors including Sofinnova Partners, XGEN Venture, CDP Venture Capital, and Indaco Venture Partners. Based on the investor page content, the company operates in the biotech and life sciences sector.

BiotechDeep TechDigital HealthHealthtech

Founders & leadership

DLDr. Lucia Faccio
Dr. Lucia FaccioChief Executive OfficerDr. Lucia Faccio holds a degree in pharmaceutical chemistry from the University of Padua and a PhD in biotechnology from the University of L'Aquila in association with Harvard Medical School. She has over 20 years of experience in life science business development, including roles as Director of Research & Development at Fondazione Telethon since 2012, Partner at Sofinnova Partners starting in 2018, and Director of the Office of Biotechnology Transfer at San Raffaele Hospital, and is now CEO of Genespire.
DJDr. Julianne Smith
Dr. Julianne SmithChief Development Officer
DSDr. Simon Hawkins
Dr. Simon HawkinsVP Clinical Development
DSDr. Smaragda Angelidou
Dr. Smaragda AngelidouResponsabile CMC
DMDr. Mary Wang
Dr. Mary WangPatient Engagement Director
EBEmanuela Balzo
Emanuela BalzoVP of FinanceEmanuela Balzo is VP Finance at Genespire, a pre-clinical gene therapy company, where she oversees financial governance and capital planning. She brings over 20 years of finance leadership across pharma and life sciences, including 12 years as Finance & Business Operations Director at Lundbeck Italia, and holds an MBA from SDA Bocconi and is a Chartered Accountant.
DSDr. Simona La Seta Catamancio
Dr. Simona La Seta CatamancioHead of Project Management
AC
Alessio CantoreFounder
LN
Luigi NaldiniFounder
DA
Dr. Albert Molina GilAssociate Director CMC

Investors · 4

Indaco Venture Partners✓ confirmed by GenespireMilan

How we know: Indaco Venture Partners's portfolio page · the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us

Sofinnova Partners✓ confirmed by GenespireParis · $540K – $27M

How we know: Sofinnova Partners's portfolio page · the company's own site · a partner's Signal profile · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

XGEN Venture✓ confirmed by GenespireMilan

How we know: the company's own site · funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$52M disclosed across 1 of 2 rounds · 2020–2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Genespire Raises €46.6M in Series B Fundingfinsmes.com · Sep 2024Genespire raises €46.6 million (~$52 million) in a Series B round to advance its first pediatric in-vivo gene therapy into the clinicglobenewswire.com · Sep 2024News - Genespiregenespire.com · Jul 2020

Frequently asked questions

What does Genespire do?
Genespire is a life sciences company backed by multiple venture capital investors including Sofinnova Partners, XGEN Venture, CDP Venture Capital, and Indaco Venture Partners. Based on the investor page content, the company operates in the biotech and life sciences sector.
Who are Genespire's investors?
Genespire's investors include CDP Venture Capital, Indaco Venture Partners, Sofinnova Partners, XGEN Venture.
How much funding has Genespire raised?
Genespire has disclosed $52M raised across 1 of its 2 known rounds.